Here are seven updates on GI companies from the past week.
Allergan reached a settlement in the whistleblower suit brought against its former Lap-Band product business. Read more.
Results from the first live, physician-supported implementation of Medial EarlySign's machine learning-based cancer-detecting solution were published in the Journal of Oncology.
Motus GI added Seth Gross, MD, to its medical advisory board.
Becker's ASC Review profiled Evoke Pharma, Pentax Medical, Fujifilm and US Endoscopy Group.